Salvage peptide receptor radionuclide therapy with [177 Lu-DOTA, Tyr 3] octreotate in patients with bronchial and gastroenteropancreatic neuroendocrine tumours - Van der Zwan, W; Brabander, T; Kam, B (European journal of nuclear medicine and molecular imaging, 2019)
et al.